卵巢子宫内膜异位症恶变及Wnt信号通路在这一过程中的研究进展
Research Progress on Malignant Transformation of Ovarian Endometriosis and Wnt Signal Pathways in This Process
DOI: 10.12677/ACM.2022.12111541, PDF,   
作者: 宋冰冰, 娄 翔:威海市妇幼保健院,山东 威海;赵孔媛:青岛大学,山东 青岛;王黎明*:青岛大学附属医院,山东 青岛
关键词: 子宫内膜异位症卵巢疾病卵巢肿瘤Wnt信号通路Endometriosis Ovarian Disease Ovarian Neoplasms Wnt Signaling Pathway
摘要: 卵巢子宫内膜异位症(ovarian endometriosis, OE)作为临床上最常见的妇科疾病之一,目前在世界各地约有1.76亿名女性受到该病影响。OE虽然是良性疾病,但其却具备浸润、转移等恶性病变的特征,恶变作为临床上OE最严重的并发症,虽然发生率低,但由于OE患病女性基数较大,OE恶变的病例总数相当可观,因此在国内外受到许多学者的高度重视。目前,许多研究认为,非典型卵巢子宫内膜异位症(atypical endometriosis, aEM)是子宫内膜异位症相关性卵巢癌(endometriosis associated ovarian cancer, EAOC)的癌前病变,OE病变组织中的良性异位子宫内膜细胞可在一定条件下转化为异位子宫内膜非典型增生,且可继续转化为异位子宫内膜恶性病变,但目前OE与EAOC之间的关系未有明确的研究及阐述。目前对EAOC的临床及基础性研究发现雌激素、氧化应激、慢性炎症等因素在其发生发展过程中发挥了重要作用,且PTEN、ARID1A、PIK3CA、miRNA等多种生物信号通路及因子也起到了重要作用。Wnt信号通路是人体细胞增殖凋亡及器官形成过程中的重要细胞信号传导通路,该通路的异常表达可促进人体多种恶性肿瘤的发生与进展。本文通过对OE恶变的研究进展及Wnt信号传导通路在这一过程中的作用进行综述,以期为EAOC的早期筛查、完善该病的分类管理、实现精准的个体化治疗方案等方面提供一定的理论依据,为潜在EAOC患者的早期诊断、早期医疗干预以及改善已确诊EAOC患者的预后提供新思路。
Abstract: Ovarian endometriosis (OE) is one of the most common gynecological diseases in clinical practice. At present, about 176 million women around the world are affected by this disease. Although OE is a benign disease, it has the characteristics of invasion, metastasis and other malignant diseases. As the most serious complication of OE in clinical practice, malignant transformation has a low inci-dence, but due to the large number of women with OE, the total number of cases of malignant trans-formation of OE is considerable, so it has been highly valued by many scholars at home and abroad. At present, many studies believe that atypical ovarian endometriosis (aEM) is a precancerous lesion of endometriosis associated ovarian cancer (EAOC). Benign ectopic endometrial cells in OE lesions can be transformed into atypical hyperplasia of ectopic endometrium under certain conditions, and can continue to be transformed into malignant lesions of ectopic endometrium, However, there is no clear research and elaboration on the relationship between OE and EAOC. At present, clinical and basic studies on EAOC have found that estrogen, oxidative stress, chronic inflammation and other factors play an important role in the occurrence and development of EAOC, and PTEN, ARID1A, PIK3CA, miRNA and other biological signal pathways and factors also play an important role. Wnt signaling pathway is an important cellular signal transduction pathway in the process of human cell proliferation, apoptosis and organ formation. The abnormal expression of this pathway can promote the occurrence and progression of various human malignant tumors. This article reviews the research progress of OE canceration and the role of Wnt signal transduction pathway in this process, with a view to providing some theoretical basis for early screening of EAOC, improving the classification management of the disease, achieving accurate individualized treatment scheme, etc., and providing new ideas for early diagnosis, early medical intervention and improving the prognosis of patients with diagnosed EAOC.
文章引用:宋冰冰, 赵孔媛, 娄翔, 王黎明. 卵巢子宫内膜异位症恶变及Wnt信号通路在这一过程中的研究进展[J]. 临床医学进展, 2022, 12(11): 10701-10710. https://doi.org/10.12677/ACM.2022.12111541

参考文献

[1] 郎景和. 对子宫内膜异位症认识的历史、现状与发展[J]. 中国实用妇科与产科杂志, 2020, 36(3): 193-196.
[2] DiVasta, A.D., Vitonis, A.F., Laufer, M.R. and Missmer, S.A. (2018) Spectrum of Symptoms in Women Diagnosed with Endometriosis during Adolescence vs Adulthood. American Journal of Obstetrics & Gynecology, 218, e1-324. [Google Scholar] [CrossRef] [PubMed]
[3] 郎景和. 子宫内膜异位症的研究与设想[J]. 中华妇产科杂志, 2003, 38(8): 478-480. [Google Scholar] [CrossRef
[4] Krawczyk, N., Banys-Paluchowski, M., Schmidt, D., Ulrich, U. and Fehm, T. (2016) Endometriosis-Associated Malignancy. Geburtshilfe und Frauenheilkunde, 76, 176-181. [Google Scholar] [CrossRef] [PubMed]
[5] Melin, A., Sparén, P., Persson, I. and Bergqvist, A. (2006) Endometriosis and the Risk of Cancer with Special Emphasis on Ovarian Cancer. Human Reproduction, 21, 1237-1242. [Google Scholar] [CrossRef] [PubMed]
[6] Melin, A., Sparén, P. and Bergqvist, A. (2007) The Risk of Cancer and the Role of Parity among Women with Endometriosis. Human Reproduction, 22, 3021-3026. [Google Scholar] [CrossRef] [PubMed]
[7] Brinton, L.A., Gridley, G., Persson, I., Baron, J. and Bergqvist, A. (1997) Cancer Risk after a Hospital Discharge Diagnosis of Endometriosis. American Journal of Obstetrics & Gyne-cology, 176, 572-579. [Google Scholar] [CrossRef
[8] Brinton, L.A., Sakoda, L.C., Sherman, M.E., et al. (2005) Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors. Cancer Epidemiology, Biomarkers & Prevention, 14, 2929-2935. [Google Scholar] [CrossRef
[9] Kobayashi, H. (2016) Potential Scenarios Leading to Ovarian Cancer Arising from Endometriosis. Redox Report, 21, 119-126. [Google Scholar] [CrossRef
[10] Bounous, V.E., Ferrero, A., Fuso, L., et al. (2016) Endo-metriosis-Associated Ovarian Cancer: A Distinct Clinical Entity? Anticancer Research, 36, 3445-3449.
[11] Sampson, J.A. (1927) Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. The American Journal of Pathology, 3, 93-110.
[12] Scott, R.B. (1953) Malignant Changes in Endometriosis. Obstetrics & Gynecology, 2, 283-289.
[13] Sampson, J.A. (1927) Peritoneal Endometriosis due to the Menstrual Dissemination of Endometrial Tissue into the Peritoneal Cavity. American Journal of Obstetrics & Gynecology, 14, 422-469. [Google Scholar] [CrossRef
[14] Kvaskoff, M., Mahamat-Saleh, Y., Farland, L.V., et al. (2021) Endometriosis and Cancer: A Systematic Review and Meta-Analysis. Human Reproduction Update, 27, 393-420. [Google Scholar] [CrossRef] [PubMed]
[15] Yachida, N., Yoshihara, K., Yamaguchi, M., Suda, K., Tamura, R. and Enomoto, T. (2021) How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development. Cancers, 13, Article No. 1439. [Google Scholar] [CrossRef] [PubMed]
[16] 王姝, 郎景和. 子宫内膜异位症相关性卵巢癌的研究现状及展望[J]. 中国实用妇科与产科杂志, 2017, 33(4): 360-364.
[17] Varga, J., Reviczká, A., Háková, H., Švajdler, P., Rabajdová, M. and Ostró, A. (2022) Predictive Factors of Endometriosis Progression into Ovarian Cancer. Journal of Ovarian Research, 15, Article No. 5. [Google Scholar] [CrossRef] [PubMed]
[18] 孙婷婷, 王姝, 刘玉婷, 郎景和. 子宫内膜异位症相关性卵巢透明细胞癌与子宫内膜样癌的临床及预后特点[J]. 生殖医学杂志, 2019, 28(4): 321-330.
[19] 赵飞, 于新平, 赵涵, 宋冰冰, 吕广伟, 张世红, 王黎明. GLI1及Shh在卵巢型子宫内膜异位症恶变过程中的表达及其意义[J]. 中华妇产科杂志, 2022, 57(2): 125-132.
[20] Li, Q., Sun, Y., Zhang, X., et al. (2019) Endometriosis-Associated Ovarian Cancer Is a Single Entity with Distinct Clinicopathological Characteristics. Cancer Biology & Therapy, 20, 1029-1034. [Google Scholar] [CrossRef] [PubMed]
[21] Davis, M.,Rauh-Hain, J.A., Andrade, C., et al. (2014) Comparison of Clinical Outcomes of Patients with Clear Cell and Endometrioid Ovarian Cancer Associated with En-dometriosis to Papillary Serous Carcinoma of the Ovary. Gynecologic Oncology, 132, 760-766. [Google Scholar] [CrossRef] [PubMed]
[22] Scarfone, G., Bergamini, A., Noli, S., et al. (2014) Characteris-tics of Clear Cell Ovarian Cancer Arising from Endometriosis: A Two Center Cohort Study. Gynecologic Oncology, 133, 480-484. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, S., Qiu, L., Lang, J.H., et al. (2013) Clinical Analysis of Ovarian Epithelial Carcinoma with Coexisting Pelvic Endometriosis. American Journal of Obstetrics & Gynecology, 208, 413.E1-413.E5. [Google Scholar] [CrossRef] [PubMed]
[24] Ye, S., Yang, J., You, Y., et al. (2014) Comparative Study of Ovarian Clear Cell Carcinoma with and without Endometriosis in People’s Republic of China. Fertility and Sterility, 102, 1656-1662. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, X., Li, M., Tang, Z., Li, X. and Song, T. (2021) Dif-ferentiation between Endometriosis-Associated Ovarian Cancers and Non- Endometriosis-Associated Ovarian Cancers Based on Magnetic Resonance Imaging. The British Journal of Radiology, 94, Article ID: 20201441. [Google Scholar] [CrossRef] [PubMed]
[26] Moss, L.D. and Runals, A.L. (1948) Carcinoma of the Ovary Arising in an Endometrial Cyst. New York State Journal of Medicine, 48, 401-406.
[27] Huang, X., Wu, B., Li, J., et al. (2019) Anti-Tumour Effects of Red Blood Cell Membrane-Camouflaged Black Phosphorous Quantum Dots Combined with Chemotherapy and Anti-Inflammatory Therapy. Artificial Cells, Nanomedicine, and Biotechnology, 47, 968-979. [Google Scholar] [CrossRef] [PubMed]
[28] Furuya, M., Tanaka, R., Miyagi, E., et al. (2012) Impaired CXCL4 Expression in Tumor-Associated Macrophages (TAMs) of Ovarian Cancers Arising in Endometriosis. Cancer Biology & Therapy, 13, 671-680. [Google Scholar] [CrossRef] [PubMed]
[29] Riccio, L.D.G.C., Santulli, P., Marcellin, L., et al. (2018) Immunology of Endometriosis. Best Practice & Research Clinical Obstetrics & Gynaecology, 50, 39-49. [Google Scholar] [CrossRef] [PubMed]
[30] Su, K.M., Wang, P.H., Yu, M.H., Chang, C.-M. and Chang, C.-C. (2020) The Recent Progress and Therapy in Endometriosis-Associated Ovarian Cancer. Journal of the Chinese Medical Association, 83, 227-232. [Google Scholar] [CrossRef
[31] Wang, Z., Liang, C., Shi, F., et al. (2017) Cancer Vaccines Using Supramolecular Hydrogels of NSAID-Modified Peptides as Adjuvants Abolish Tumorigenesis. Nanoscale, 9, 14058-14064. [Google Scholar] [CrossRef
[32] 魏巧红, 武晓红. 子宫内膜异位症相关性卵巢癌的研究进展[J]. 肿瘤研究与临床, 2022, 34(3): 227-230.
[33] Guo, S.W. (2020) Cancer-Associated Mutations in En-dometriosis: Shedding Light on the Pathogenesis and Pathophysiology. Human Reproduction Update, 26, 423-449. [Google Scholar] [CrossRef] [PubMed]
[34] Bulun, S.E., Wan, Y. and Matei, D. (2019) Epithelial Mutations in Endometriosis: Link to Ovarian Cancer. Endocrinology, 160, 626-638. [Google Scholar] [CrossRef] [PubMed]
[35] Iwabuchi, T., Yoshimoto, C., Shigetomi, H. and Kobayashi, H. (2015) Oxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant Transformation. Oxidative Medicine and Cellular Longevity, 2015, Article ID: 848595. [Google Scholar] [CrossRef] [PubMed]
[36] Amano, T., Murakami, A., Murakami, T. and Chano, T. (2021) Anti-oxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma. Antioxidants, 10, Article No. 187. [Google Scholar] [CrossRef] [PubMed]
[37] Kobayashi, H., Yamada, Y., Kawahara, N., Ogawa, K. and Yoshimoto, C. (2019) Integrating Modern Approaches to Pathogenetic Concepts of Malignant Transformation of Endometriosis. Oncology Reports, 41, 1729-1738. [Google Scholar] [CrossRef] [PubMed]
[38] Xie, H., Chen, P., Huang, H.W., Liu, L.P. and Zhao, F. (2017) Reactive Oxygen Species Down-Regulate ARID1A Expression via Its Promoter Methylation during the Pathogenesis of Endometriosis. European Review for Medical and Pharmacological Sciences, 21, 4509-4515.
[39] Stewart, C.J., Leung, Y., Walsh, M.D., et al. (2012) KRAS Mutations in Ovarian Low-Grade Endometrioid Adenocarcinoma: Association with Concurrent Endometriosis. Human Pathology, 43, 1177-1183. [Google Scholar] [CrossRef] [PubMed]
[40] Bastu, E., Onder, S., Demiral, I., et al. (2018) Distinguishing the Progression of an Endometrioma: Benign or Malignant? European Journal of Obstetrics & Gynecology and Re-productive Biology, 230, 79-84. [Google Scholar] [CrossRef] [PubMed]
[41] Sansal, I. and Sellers, W.R. (2004) The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway. Journal of Clinical Oncology, 22, 2954-2963. [Google Scholar] [CrossRef
[42] Dinulescu, D.M., Ince, T.A., Quade, B.J., Shafer, S.A., Crowley, D. and Jacks, T. (2005) Role of K-ras and Pten in the Development of Mouse Models of Endometriosis and Endometrioid Ovarian Cancer. Nature Medicine, 11, 63-70. [Google Scholar] [CrossRef] [PubMed]
[43] Ma, X., Hui, Y., Lin, L., Wu, Y., Zhang, X. and Qin, X. (2016) Possible Relevance of Tumor-Related Genes Mutation to Malignant Transformation of Endometriosis. European Journal of Gynaecological Oncology, 37, 89-94.
[44] 叶云, 黄紫艳, 陈颖. 雌激素受体PTEN及环氧合酶-2在子宫内膜异位症相关性卵巢癌患者中的表达[J]. 中国妇幼保健, 2021, 36(5): 1168-1171. [Google Scholar] [CrossRef
[45] Lv, J., Zhu, Q., Jia, X., Yu, N. and Li, Q. (2016) In Vitro and in Vivo Effects of Tumor Suppressor Gene PTEN on Endometriosis: An Experimental Study. Medical Science Monitor, 22, 3727-3736. [Google Scholar] [CrossRef
[46] Trizzino, M., Barbieri, E., Petracovici, A., et al. (2018) The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase Ⅱ. Cell Reports, 23, 3933-3945. [Google Scholar] [CrossRef] [PubMed]
[47] Jones, S., Wang, T.L., Shih, I.-M., et al. (2010) Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma. Science, 330, 228-231. [Google Scholar] [CrossRef] [PubMed]
[48] Kurman, R.J. and Shih, I.-M. (2011) Molecular Pathogenesis and Extraovarian Origin of Epithelial Ovarian Cancer—Shifting the Paradigm. Human Pathology, 42, 918-931. [Google Scholar] [CrossRef] [PubMed]
[49] Wiegand, K.C., Hennessy, B.T., Leung, S., et al. (2014) A Functional Proteogenomic Analysis of Endometrioid and Clear Cell Carcinomas Using Reverse Phase Protein Array and Mutation Analysis: Protein Expression Is Histotype-Specific and Loss of ARID1A/BAF250a Is Associated with AKT Phosphorylation. BMC Cancer, 14, Article No. 120. [Google Scholar] [CrossRef] [PubMed]
[50] Yamamoto, S., Tsuda, H., Takano, M., Tamai, S. and Matsubara, O. (2012) Loss of ARID1A Protein Expression Occurs as an Early Event in Ovarian Clear Cell Carcinoma Development and Frequently Coexists with PIK3CA Mutations. Modern Pathology, 25, 615-624. [Google Scholar] [CrossRef] [PubMed]
[51] Suda, K., Cruz Diaz, L.A., Yoshihara, K., et al. (2020) Clonal Lineage from Normal Endometrium to Ovarian Clear Cell Carcinoma through Ovarian Endometriosis. Cancer Science, 111, 3000-3009. [Google Scholar] [CrossRef] [PubMed]
[52] Madanes, D., Bilotas, M.A., Bastón, J.I., et al. (2020) PI3K/AKT Pathway Is Altered in the Endometriosis Patient’s Endometrium and Presents Differences According to Severity Stage. Gynecological Endocrinology, 36, 436-440. [Google Scholar] [CrossRef] [PubMed]
[53] Wilbur, M.A., Shih, I.M., Segars, J.H. and Fader, A.N. (2017) Can-cer Implications for Patients with Endometriosis. Seminars in Reproductive Medicine, 35, 110-116. [Google Scholar] [CrossRef] [PubMed]
[54] 魏娜, 韩萍. P53、ki-67的表达与上皮性卵巢癌预后相关性分析[J]. 华北理工大学学报(医学版), 2019, 21(6): 454-459. [Google Scholar] [CrossRef
[55] 王丽宏, 叶霞, 吕家峰. 卵巢子宫内膜异位症恶性变过程中p53蛋白的表达变化[J]. 基层医学论坛, 2015, 19(33): 4614-4615, 4616.
[56] Akahane, T., Sekizawa, A., Purwosunu, Y., Nagatsuka, M. and Okai, T. (2007) The Role of p53 Mutation in the Carcinomas Arising from En-dometriosis. International Journal of Gynecological Pathology, 26, 345-351. [Google Scholar] [CrossRef] [PubMed]
[57] 刘丽丹. 蛋白激酶CK2β及抑癌基因蛋白p53在卵巢癌组织中的表达[J]. 中国妇幼保健, 2017, 32(19): 4818-4821.
[58] Wu, R.L., Ali, S., Bandyopadhyay, S., et al. (2015) Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis. Journal of Cancer Science & Therapy, 7, 258-265.
[59] Gaia-Oltean, A.I., Braicu, C., Gulei, D., et al. (2021) Ovarian Endometriosis, a Precursor of Ovarian Cancer: Histological Aspects, Gene Expression and microRNA Alterations (Review). Experimental and Therapeutic Medicine, 21, 243-243. [Google Scholar] [CrossRef] [PubMed]
[60] Pavone, M.E. and Lyttle, B.M. (2015) Endometriosis and Ovarian cancer: Links, Risks, and Challenges Faced. International Journal of Women’s Health, 7, 663-672. [Google Scholar] [CrossRef
[61] Braicu, O.L., Budisan, L., Buiga, R., et al. (2017) miRNA Expression Profiling in Formalin-Fixed Paraffin-Embedded Endometriosis and Ovarian Cancer Samples. OncoTargets and Therapy, 10, 4225-4238. [Google Scholar] [CrossRef
[62] Marí-Alexandre, J., Carcelén, A.P., Agababyan, C., et al. (2019) In-terplay between microRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endo-metriosis. International Journal of Molecular Sciences, 20, Article No. 5322. [Google Scholar] [CrossRef] [PubMed]
[63] 杨永彬, 刘玲, 王炎秋, 杨懿霞, 万小平. 卵巢和卵巢肿瘤中Hedgehog信号通路的表达[J]. 上海交通大学学报(医学版), 2009, 29(4): 426-430.
[64] 朱奕晓, 王艳. Hedgehog信号通路与常见妇科恶性肿瘤的研究进展[J]. 医学综述, 2017, 23(12): 2364-2369.
[65] Deb, B., Uddin, A. and Chakraborty, S. (2018) miRNAs and Ovarian Cancer: An Overview. Journal of Cellular Physiology, 233, 3846-3854. [Google Scholar] [CrossRef] [PubMed]
[66] Nguyen, V.H.L., Hough, R., Bernaudo, S. and Peng, C. (2019) Wnt/β-Catenin Signalling in Ovarian Cancer: Insights into Its Hyperactivation and Function in Tumorigenesis. Journal of Ovarian Research, 12, Article No. 122. [Google Scholar] [CrossRef] [PubMed]
[67] 李孝琼, 肖云峰, 吴妮莎, 徐黎明, 罗博, 周国俊, 冷政伟. 肿瘤干细胞及Wnt/β-catenin信号通路在结直肠癌肝转移中的作用[J]. 中华肝脏外科手术学电子杂志, 2019, 8(4): 377-378.
[68] Adamson, G.D., Kennedy, S.H. and Hummelshoj, L. (2010) Creating Solutions in Endometriosis: Global Collaboration through the World Endometriosis Research Foundation. Journal of Endometriosis and Pelvic Pain Disorders, 2, 3-6. [Google Scholar] [CrossRef
[69] 范晓杰, 王心然, 岳萌, 等. PD-L1在三阴性乳腺癌组织中表达及其与脉管生成的关系[J]. 中国肿瘤生物治疗杂志, 2019, 26(11): 1229-1234.
[70] Goldsberry, W.N., Me-za-Perez, S., Londoño, A.I., Katre, A.A., Mott, B.T., Roane, B.M., Goel, N., Wall, J.A., Cooper, S.J., Norian, L.A., Randall, T.D., Birrer, M.J. and Arend, R.C. (2020) Inhibiting WNT Ligand Production for Improved Immune Recogni-tion in the Ovarian Tumor Microenvironment. Cancers, 12, Article No. 766. [Google Scholar] [CrossRef] [PubMed]
[71] Stamos, J.L. and Weis, W.I. (2013) The β-Catenin Destruction Complex. Cold Spring Harbor Perspectives in Biology, 5, a007898. [Google Scholar] [CrossRef] [PubMed]
[72] Fu, F., Deng, Q., Li, R., Wang, D., Yu, Q.X., Yang, X., Lei, T.Y., Han, J., Pan, M., Zhen, L., Li, J., Li, F.T., Zhang, Y.L., Li, D.Z. and Liao, C. (2020) AXIN2 Gene Silencing Re-duces Apoptosis through Regulating Mitochondria-Associated Apoptosis Signaling Pathway and Enhances Proliferation of ESCs by Modulating Wnt/β-Catenin Signaling Pathway. European Review for Medical and Pharmacological Sciences, 24, 418-427.
[73] 陶玲, 于春霞, 李霞, 周琦. β-连环蛋白、轴蛋白在卵巢上皮细胞癌组织中的表达及意义[J]. 中国妇幼保健, 2015, 30(15): 2356-2358.
[74] 李艳, 马玲, 张伊莉, 蒋涛, 毕国斌, 邵晨. β-catenin、Axin在卵巢上皮细胞癌组织中的表达及临床意义[J]. 现代中西医结合杂志, 2017, 26(26): 2871-2873, 2957.